This archive report was first published on 19 June 2020.
Published on June 19, 2020, the World Health Organization (WHO) is optimistic about the development of a COVID-19 vaccine, with a goal of having about two billion doses available by the end of 2021.
WHO's chief scientist, Dr. Soumya Swaminathan, emphasized that this target is contingent upon the availability of a proven vaccine, stating, “It’s a big ‘if’ because we don’t have any vaccine that’s proven.”
Despite this uncertainty, Dr. Swaminathan expressed encouragement about the numerous potential vaccines currently undergoing testing, with the hope that at least one or two would be ready for use by next year.
The WHO recommends prioritizing immunization for high-risk groups, including the elderly, those with underlying conditions, and key workers. However, countries must come to a consensus on which populations to prioritize.
Several developed countries, including Britain, France, the Netherlands, Germany, and the U.S., have already secured vaccine supplies through deals with pharmaceutical firms.
EU Commission President Ursula von der Leyen announced a donor conference on June 28 to raise funds for equitable access to COVID-19 vaccines and treatments.
Dr. Swaminathan emphasized the importance of global cooperation in fighting the pandemic, stating, “There is no place for ‘Me first’ when it comes to fighting a global pandemic.”
